Segrelles, C.; Contreras, D.; Navarro, E.M.; Gutiérrez-Muñoz, C.; García-Escudero, R.; Paramio, J.M.; Lorz, C.
Bosutinib Inhibits EGFR Activation in Head and Neck Cancer. Int. J. Mol. Sci. 2018, 19, 1824.
https://doi.org/10.3390/ijms19071824
AMA Style
Segrelles C, Contreras D, Navarro EM, Gutiérrez-Muñoz C, García-Escudero R, Paramio JM, Lorz C.
Bosutinib Inhibits EGFR Activation in Head and Neck Cancer. International Journal of Molecular Sciences. 2018; 19(7):1824.
https://doi.org/10.3390/ijms19071824
Chicago/Turabian Style
Segrelles, Carmen, David Contreras, Elena M. Navarro, Carmen Gutiérrez-Muñoz, Ramón García-Escudero, Jesús M. Paramio, and Corina Lorz.
2018. "Bosutinib Inhibits EGFR Activation in Head and Neck Cancer" International Journal of Molecular Sciences 19, no. 7: 1824.
https://doi.org/10.3390/ijms19071824
APA Style
Segrelles, C., Contreras, D., Navarro, E. M., Gutiérrez-Muñoz, C., García-Escudero, R., Paramio, J. M., & Lorz, C.
(2018). Bosutinib Inhibits EGFR Activation in Head and Neck Cancer. International Journal of Molecular Sciences, 19(7), 1824.
https://doi.org/10.3390/ijms19071824